ValGenesis and Scignyte to Drive Digital Transformation Across Asia
ValGenesis and Scignyte provide an integrated governance approach with streamlined collaboration and data integrity, further strengthening risk and compliance across R&D processes.
_________________
February 7, 2023 | ValGenesis and Scignyte provide an integrated governance approach with streamlined collaboration and data integrity, further strengthening risk and compliance across R&D processes.
ValGenesis News
ValGenesis and Scignyte provide an integrated governance approach with streamlined collaboration and data integrity, further strengthening risk and compliance across R&D processes.
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), today announced that a leading pharmaceutical manufacturer selected ValGenesis VLMS to digitize multiple validation processes across the organization after a rigorous audit of possible solutions.
In this partnership, QualiTech will implement and manage next-generation digital validation tools developed by ValGenesis, enabling clients to further strengthen risk and compliance across the GMP lifecycle.
“Digitizing validation processes is crucial for compliance-focused life sciences companies to be able to meet stringent global regulatory requirements,” says Dr. Siva Samy, CEO & Chief Product Strategist at ValGenesis.
ValGenesis, Inc and Orbis LabSystems have partnered to deliver best-in-class digital validation solutions for life science companies across Europe, with a focus on Ireland.
ValGenesis VLMS enforces standardization and compliance with 100% digital, risk-based validation software that integrates easily with any business system. This leads to significant gains, better monitoring, and adequate utilization of systems.
ValGenesis, Inc and LifeBee have partnered to deliver best-in-class business consulting and innovative digital validation solutions in GxP regulated areas such as manufacturing, quality assurance, laboratories, logistics, serialization, regulatory affairs and pharmacovigilance for biopharmaceutical, medical devices, and nutraceutical companies across Italy and Switzerland.
The company is building out a new, GMP-compliant facility for a new fermented product being brought to market. The company will implement the VLMS for equipment qualification and use ValGenesis e-Logbook for continuous monitoring of the equipment at their new facility.
The acquisition was initiated when ValGenesis leadership saw the strategic product synergy for customers requiring a complete and more integrated platform across the validation lifecycle focusing on Pharma 4.0.
This is the largest consumer goods company based in the U.K. to implement ValGenesis VLMS. The system will drive all the company’s validation programs, including computer system validation (CSV) and equipment qualification.